Ohashi, M <br/><br/>
Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism.  [electronic resource] 

 -  Japanese journal of cancer research : Gann  Sep 1995 
 - 819-27 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0910-5050 
<br/><br/><label>Standard No.: </label>10.1111/j.1349-7006.1995.tb03091.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Apoptosis--drug effects<br/>CDC2-CDC28 Kinases<br/>Carcinoma, Lewis Lung--drug therapy<br/>Cell Death--drug effects<br/>Cell Division--drug effects<br/>Colonic Neoplasms--drug therapy<br/>Cyclin-Dependent Kinase 2<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Ellipticines--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Histones--metabolism<br/>Humans<br/>Mice<br/>Mice, Inbred Strains<br/>Microsomes--drug effects<br/>Phosphorylation--drug effects<br/>Precipitin Tests<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Topoisomerase II Inhibitors<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p53--metabolism